← Open Payments lookup

MARK BASIRATMAND: Open Payments

NPI 1154836153 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,318 in 35 payments from 9 companies in 2025. Trend: 2023 $709 · 2024 $1,751 · 2025 $1,318

Food & beverage: $1,318
CompanyPaymentsAmount
Amgen Inc.12$342
Novo Nordisk Inc11$329
Ardelyx, Inc.4$203
Madrigal Pharmaceuticals1$150
ABBVIE INC.1$143
Lilly USA, LLC2$56
Intra-Sana Laboratories2$56
GlaxoSmithKline, LLC.1$22
Kowa Pharmaceuticals America, Inc.1$18

Products named: REPATHA, Ozempic, IBSRELA, REZDIFFRA, CREON, Rybelsus, RELTONE 200 MG, OTEZLA.

Industry payments across NY — which companies pay providers there.